Literature DB >> 24327985

Clinicopathological significance of atypical glandular cells on Pap smear.

Sun-Suk Kim1, Dong-Soo Suh, Ki-Hyung Kim, Man-Soo Yoon, Kyung-Un Choi.   

Abstract

OBJECTIVE: To investigate the clinical significance of atypical glandular cells (AGC) by analyzing the prevalence and histologic outcomes of patients with AGC according to Pap smear.
METHODS: The medical records of 83 patients who were diagnosed AGC on Pap tests at the Pusan National University Hospital outpatient department and health care center from January 1998 to March 2006 were reviewed.
RESULTS: The prevalence of AGC was 55 of 54,160 (0.10%) and 28 of 54,160 (0.05%) for AGC-not otherwise specified (NOS) and neoplastic associated AGC, respectively. The histopathologic results of the AGC-NOS group (n=55) were as follows: low-grade squamous intraepithelial lesion, 7 (12.7%); high-grade squamous intraepithelial lesion, 4 (7.2%); adenocarcinoma of cervix, 3 (5.4%); endometrial carcinoma, 2 (3.6%); and other malignancies including 2 ovarian cancer cases and 1 breast cancer case, 3 (5.4%). The histopathologic results for the AGC-associated neoplastic group (n=28) were as follows: low-grade squamous intraepithelial lesion, 1 (3.5%); high-grade squamous intraepithelial lesion, 3 (10.7%); adenocarcinoma of cervix, 5 (17.8%); endometrial carcinoma, 4 (4.8%); and additional malignancies including 3 stomach cancer cases, 2 ovarian cancer cases, and 2 breast cancer cases; 7 (25%).
CONCLUSION: AGCs may represent a variety of benign and malignant lesions. AGC-associated neoplastic findings may be related to gynecological or extrauterine malignancies. Thus, when AGCs, especially neoplastic AGCs, are encountered, it is best to evaluate the cervix not only for typical maladies, but also for gynecological and non-gynecological malignancies.

Entities:  

Keywords:  Atypical glandular cell; Pap smear

Year:  2013        PMID: 24327985      PMCID: PMC3784096          DOI: 10.5468/OGS.2013.56.2.76

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  16 in total

Review 1.  Management of atypical squamous cells of undetermined significance and low-grade squamous intra-epithelial lesion by human papillomavirus testing.

Authors:  J T Cox
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2001-10       Impact factor: 5.237

2.  Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses.

Authors:  W K Kinney; M M Manos; L B Hurley; J E Ransley
Journal:  Obstet Gynecol       Date:  1998-06       Impact factor: 7.661

3.  Clinical implications of atypical glandular cells of undetermined significance, favor endometrial origin.

Authors:  D C Chhieng; P Elgert; J M Cohen; J F Cangiarella
Journal:  Cancer       Date:  2001-12-25       Impact factor: 6.860

Review 4.  Clinical significance of atypical glandular cells on cervical cytology.

Authors:  Peter F Schnatz; Matthew Guile; David M O'Sullivan; Joel I Sorosky
Journal:  Obstet Gynecol       Date:  2006-03       Impact factor: 7.661

Review 5.  The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29-30, 1991.

Authors: 
Journal:  Acta Cytol       Date:  1993 Mar-Apr       Impact factor: 2.319

Review 6.  Atypical glandular cells of undetermined significance. Review of final histologic diagnoses.

Authors:  Amy J Meath; Michael E Carley; Timothy O Wilson
Journal:  J Reprod Med       Date:  2002-04       Impact factor: 0.142

7.  Atypical glandular cells on cervical cytology and breast disease: what is the association?

Authors:  Peter F Schnatz; Kristine Pattison; Srinivas Mandavilli; Mary Fiel-Gan; Ossama Aly Elsaccar; David M O'Sullivan; Kathryn E Sharpless
Journal:  J Low Genit Tract Dis       Date:  2011-07       Impact factor: 1.925

Review 8.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

9.  Low-grade Papanicolaou smears and the Bethesda system: a prospective cytohistopathologic analysis.

Authors:  N M Lonky; G L Navarre; S Saunders; M Sadeghi; G Wolde-Tsadik
Journal:  Obstet Gynecol       Date:  1995-05       Impact factor: 7.661

10.  Natural history of cervical squamous intraepithelial lesions: a meta-analysis.

Authors:  J Melnikow; J Nuovo; A R Willan; B K Chan; L P Howell
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

View more
  4 in total

1.  Increased methylation of human papillomavirus type 16 DNA is associated with the severity of cervical lesions in infected females from northeast China.

Authors:  Wei Wang; Zhengrong Sun; Jianhua Liu; Guili Wang; Zhitao Lu; Weiqiang Zhou; Te Qi; Qiang Ruan
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

2.  Atypical endometrial cells and atypical glandular cells favor endometrial origin in Papanicolaou cervicovaginal tests: Correlation with histologic follow-up and abnormal clinical presentations.

Authors:  Longwen Chen; Christine N Booth; Julie A Shorie; Jennifer A Brainard; Matthew A Zarka
Journal:  Cytojournal       Date:  2014-11-14       Impact factor: 2.091

3.  Histological Follow-Up in Patients with Atypical Glandular Cells on Pap Smears.

Authors:  Gokhan Boyraz; Derman Basaran; Mehmet Coskun Salman; Akbar Ibrahimov; Sevgen Onder; Orkun Akman; Nejat Ozgul; Kunter Yuce
Journal:  J Cytol       Date:  2017 Oct-Dec       Impact factor: 1.000

4.  More focus on atypical glandular cells in cervical screening: Risk of significant abnormalities and low histological follow-up rate.

Authors:  Pingping Zhong; Chenghong Yin; Yulan Jin; Tianbao Chen; Yang Zhan; Cheng Tian; Li Zhu; Xingzheng Zheng
Journal:  Cytojournal       Date:  2020-10-06       Impact factor: 2.091

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.